Ocular Therapeutix Inc (OCUL)

R&D Expenses

$223.51M

TTM · Period ending: · USD

OCUL logo

OCUL R&D Expenses

Latest reported$223.51M
OCUL TTM R&D Expenses ($10.52M → $223.51M)
High-resolution chart · PNG

OCUL r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ocular Therapeutix Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
223,509,000
220,452,000
197,096,000
187,285,000
171,981,000
149,757,000
127,635,000
102,841,000
80,806,000
67,043,000
61,055,000
58,403,000
57,103,000
55,109,000
53,462,000
52,497,000
51,497,000
52,256,000
50,083,000
45,129,000
39,361,000
33,523,000
28,694,000
31,195,000
34,479,000
35,872,000
41,091,000
41,224,000
40,674,000
40,005,000
36,915,000
34,565,000
33,006,000
32,378,000
30,880,000
30,300,000
27,860,000
26,721,000
27,065,000
26,623,000
29,200,000
28,965,000
26,611,000
24,873,000
21,092,000
18,641,000
18,880,000
16,574,000
14,876,000
12,988,000
10,517,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.